Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.

Antimicrobial agents and chemotherapy - 1 Nov 2001

Klein J L, Brown T J, French G L

Abstract excerpt

Rifampin is the most potent drug used in the treatment of disease due to Mycobacterium kansasii. A 69-bp fragment of rpoB, the gene that encodes the beta subunit of the bacterial RNA polymerase, was sequenced and found to be identical in five rifampin-susceptible clinical isolates of M. kansasii....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antitubercular
Share to DNA, Bacterial
Share to DNA-Directed RNA Polymerases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Microbial Sensitivity Tests

Share to Mycobacterium Infections

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Rifampin

Source

Open in PubMed Open full text

Identifiers

PMID: 11600355
DOI: 10.1128/AAC.45.11.3056-3058.2001
PMCID: PMC90781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11600355-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.PMID 11600355Read ↗

[Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii].Semantic proximity Read ↗

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.Semantic proximity Read ↗

Characterization of rifampin-resistance in pathogenic mycobacteria.Semantic proximity Read ↗

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.Semantic proximity Read ↗

Antimicrobial agent resistance in mycobacteria: molecular genetic insights.Semantic proximity Read ↗

Antimicrobial agent resistance in mycobacteria: molecular genetic insights.Semantic proximity Read ↗

Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East.Semantic proximity Read ↗

Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.Semantic proximity Read ↗

Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico.Semantic proximity Read ↗

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.Semantic proximity Read ↗

Detection of Resistance to Isoniazid, Rifampin, and Streptomycin in Clinical Isolates of Mycobacterium tuberculosis by Molecular MethodsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.